Here, we use in vitro and in vivo models to identify ectopically expressed BRDT as a factor promoting tumor growth, indicating BRDT as a potential therapeutic target in lung cancers with ectopic BRDT expression. The gene discussed is BRDT; the disease is neoplasm.